Bing Center for Waldenstrom's Macroglobulinemia - Comparative Outcomes Following CP-R, CVP-R, and CHOP-R in WM - Boston Patient & Physician Summit, May 2009, Thea Ioakimidis

You are here: Home

Media

Comparative Outcomes Following CP-R, CVP-R, and CHOP-R in WM - Boston Patient & Physician Summit, May 2009, Thea Ioakimidis

Date: May 2, 2009 Location: 3rd International Patient & Physician Summit on WM, Boston, MA
Lecturer: Thea Ioakimidis, Bing Center for WM Subject: Comparative Outcomes Following CP-R, CVP-R, and CHOP-R in Patients with WM

Click video player to start video. NOTE: It may take a few minutes for video to load. Use the navigation controls in the PDF viewer to view the corresponding slide in the lecture.

Latest Bing Center News

My Waldenström Macroglobulinemia, Miracle Number Three

Dear Fellow Cancer Patient: As I believe in universal love for ALL, I’m reaching out to you, whether we have met or not, to invite you to join me in embracing the concept of medical miracles no matter what kind of cancer you have.

Update on Bing Neel Syndrome - Shayna Sarosiek April, 2023

From Bing-Neel Co-Leader & Lifeline Volunteer, Julie Davidson: "The Bing-Neel Support Group just had our Spring meeting. We featured a wonderfully informative video by Dr. Shayna Sarosiek, senior physician at the Dana-Farber Cancer Institute’s Bing Center for Waldenstrom’s Macroglobulinemia.

2022 March Dr. Treon "Rounds" with Canadian Medical Professionals

We invited Canadian medical professionals to listen to Dr. Treon of the DFCI. (There were 2 sessions - EST & PST) He provided a very thorough update on the state of WM and its treatment.

IWWM-11 (Madrid 2022) Consensus Panel Reports

Consensus panel reports from the 11th International Workshop on Waldenstrom's Macroglobulinemia.

Dana-Farber Researchers Use Machine Learning to Understand Rare Familial Blood Cancer

Researchers at Dana-Farber have put together a data atlas that includes a range of genomic, transcriptomic, epigenetic, and clinical data from patients and healthy donors to try to understand familial WM.

Topics from the 11th IWWM Workshop in Madrid

Bing Center WM experts discuss various topics from the 11th IWWM in Madrid.

Expert Advice for Newly Diagnosed Waldenström Macroglobulinemia (WM) Patients

What should you know if you or a loved one has been diagnosed with Waldenström macroglobulinemia (WM)? Dr. Shayna Sarosiek of the Dana-Farber Cancer Institute shares key advice.

Talking with your Waldenstrom's Macroglobulinemia Patients

This document, written by Drs. Jorge Castillo and Shayna Sarosiek, provides a reference guide to assist medical professionals in discussions with WM patients. Patients can give this booklet to their PCP, oncologist, or other health care provider in order to help familiarize them with this uncommon disease.

2022 ASH Conference Report: Waldenstrom Macroglobulinemia

From the 64th ASH Annual Meeting, Jorge Castillo, MD, Clinical Director of the Bing Center for Waldenström’s Macroglobulinemia at Dana-Farber Cancer Institute in Boston, updates our Waldenström patient community on important research results presented this year, offers guidance on finding relevant clinical trials, and highlights what to look for in the coming year.

RECORDING AVAILABLE - Treatment, Trials, and Hope-For ALL Stages of Disease

RECORDING NOW AVIALABLE! Join IWMF on ZOOM for this very important topic that affects everyone with a WM diagnosis! Dr. Jorge Castillo presents - Treatments, Trials, and Hope – for ALL Stages of Disease. Dr. Castillo is a GLOBAL SPECIALIST IN Waldenstrom's Macroglobulinemia (WM) AND Clinical Director of the Bing Center Clinic (for WM) at Dana-Farber Cancer Institute.

Legal | Privacy